These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22621940)

  • 41. Longitudinal study of normal cognition in Parkinson disease.
    Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
    Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.
    Goldman WP; Baty JD; Buckles VD; Sahrmann S; Morris JC
    Arch Neurol; 1998 May; 55(5):674-80. PubMed ID: 9605724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson's disease, cognition and aging. Clinical, neuropsychological, electrophysiological and cranial computerized tomographic assessment.
    Elwan OH; Baradah OH; Madkour O; Elwan H; Hassan AA; Elwan F; Mahfouz M; Ali A; Fahmy M
    J Neurol Sci; 1996 Nov; 143(1-2):64-71. PubMed ID: 8981300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Lundin KF; Edström M; Forsgren L
    Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysfunctional action control as a specific feature of Parkinson's disease.
    Marzinzik F; Herrmann A; Gogarten JH; Lueschow A; Weber JE; Schindlbeck KA; Klostermann F
    J Neural Transm (Vienna); 2015 Aug; 122(8):1125-33. PubMed ID: 25547860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia.
    Martin RC; Okonkwo OC; Hill J; Griffith HR; Triebel K; Bartolucci A; Nicholas AP; Watts RL; Stover N; Harrell LE; Clark D; Marson DC
    Mov Disord; 2008 Oct; 23(13):1867-74. PubMed ID: 18759361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
    Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between cognition and function in patients with Parkinson disease with and without dementia.
    Rosenthal E; Brennan L; Xie S; Hurtig H; Milber J; Weintraub D; Karlawish J; Siderowf A
    Mov Disord; 2010 Jul; 25(9):1170-6. PubMed ID: 20310053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visuoconstructional problems in dementia: contribution of executive systems functions.
    Freeman RQ; Giovannetti T; Lamar M; Cloud BS; Stern RA; Kaplan E; Libon DJ
    Neuropsychology; 2000 Jul; 14(3):415-26. PubMed ID: 10928745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive impairments in different stages of Parkinson's disease.
    Starkstein SE; Bolduc PL; Preziosi TJ; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):243-8. PubMed ID: 2521068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropsychological profile of patients with Parkinson's disease without dementia.
    Janvin C; Aarsland D; Larsen JP; Hugdahl K
    Dement Geriatr Cogn Disord; 2003; 15(3):126-31. PubMed ID: 12584427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
    Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
    Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.